Refine by
Therapy Monitoring Articles & Analysis
19 news found
Particles Plus® instruments have once again been used by scientists for research into Nebulizer Inhalation Therapy. To test the administration of safe Nebulizer Inhalation Therapy, researchers monitored particle concentrations for different particle sizes with Particles Plus® Optical Particle Counters (OPC). ...
The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...
BIOMARK RECEIVES FUNDING SUPPORTING RESEARCH AND DEVELOPMENT PROJECT FOR CANCER TREATMENT MONITORING Vancouver, British Columbia – (February 7th, 2023) – BioMark Diagnostics Inc. ...
Alzheimer’s remains a complex condition and our involvement in this trial means that monitoring the interaction between the cortical microstructure and neuroinflammation offers the potential for a new angle on our understanding of the disease. ...
” UK 1st National Health Service (NHS) EndoBarrier Service for Uncontrolled Diabesity In the first NHS EndoBarrier service in the U.K., EndoBarrier was provided to patients with uncontrolled diabesity despite all available standard therapies and monitored in the ABCD Worldwide Registry. Data presented at ADA was for 4-year outcomes for all 62 treated ...
The purpose of the assay, when it becomes clinically available in Q1 2023, will be to enable clinicians to monitor patients’ responses to therapies, including in late-stage cancers for which minimal residual disease (MRD) assays may not be as informative or effective. ...
Ab medica starts from the many years of monitoring, developing a Class IIA Medical Device, compliant with the GDPR regulation and easily integrated with public and private information systems. Maia connected care is a modular platform that allows Telemonitoring, Television, Telerehabilitation and Pharmacological Therapy. It allows spot or continuous ...
Also, real-world clinical outcomes data from the GuardantINFORM™ platform showed that colorectal cancer patients who received immune checkpoint blockade therapy after MSI-H status identification with Guardant360 achieved responses in line with published data in previously treated MSI-H advanced gastrointestinal cancers1,2. (Abstract 56) “These studies further ...
“We believe these two-year results demonstrate the potential of this gene therapy candidate to minimize significant symptoms associated with hemophilia A and become an alternative to the current burden of disease ...
Focal Healthcare has licensed patents from the Centre for Imaging Technology Commercialization (CIMTEC) that will be used in 3D ultrasound-based point of care diagnostic and monitoring systems. The technology will be used at the patient’s bedside to image joints, organs and blood vessels. ...
This new 5x7 OxySpur oxygen diffusion dressing is part of the OxyGeni System which provides a complete oxygen therapy and wound monitoring system. Continuous Diffusion of Oxygen (CDO) therapy provides full closure and pain relief to patients dealing with chronic, ischemic or surgical wounds. ...
SAGA’s platform technologies, which are based on digital PCR and next-generation sequencing, are tools to be used in cancer patient stratification, therapy response monitoring, disease relapse identification, as well as in aiding in treatment decisions and as companion diagnostics. ...
Signifier Medical Technologies (“Signifier” or “the Company”), an innovator in the sleep disordered breathing market, is pleased to announce the successful award of the UK Non-invasive Ventilation, Sleep Therapy and Sleep Monitoring Tender, which will confirm Signifier as an approved supplier to the UK’s National Health Service ...
Exacting image quality replication from the original image easy to administer and manage Contrast Enhanced breast imaging, physician directed, with standard CT contrast solutions (not required on all patients) superb implant imaging without the use of displacement views rapid and accurate neoadjuvant therapy monitoring as needed Breast CT technology ...
New published data demonstrating 14-3-3η as a biomarker for monitoring Tofacitinib therapy response in RA patients 14-3-3η is a modifiable marker of joint damage progression risk, which makes it ideal to track over time for the optimization of RA treat-to-target strategies to improve clinical and radiographic outcomes. ...
As a highlight, one study describes how 14-3-3η levels can assist with monitoring patients on Tofacitinib therapy. 14-3-3η is a modifiable marker of joint damage progression risk, which makes it ideal to track over time for the optimisation of RA treat-to-target strategies to improve clinical and radiographic outcomes. ...
The standardized approach for monitoring the effectiveness of the therapy involves the repeated quantitative measurement of the patient’s HCV RNA levels. ...
Profusa, Inc., a developer of tissue-integrated biosensors for continuous monitoring of body chemistry, today announced that it received the CE Mark to market its Lumee Oxygen Platform™ for continuous, real-time monitoring of tissue oxygen. ...
Abbott Molecular's instruments and assays are used for early detection and diagnosis of disease, to influence the selection of appropriate therapies and as an aid in monitoring disease progression. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical ...